Related by context. Frequent words. (Click for all words.) 66 Q3 Loss Narrows 65 Q4 Profit Surges 65 Q2 Loss Narrows 64 Lowers Guidance 64 Q4 Loss Narrows 63 Q2 Loss Widens 63 Q1 Loss Widens 62 CEO Exercises Options 62 Earnings Scorecard 62 Guides Above 62 ALGN 62 Q1 Loss Narrows 61 Q3 Loss Widens 61 Movers Roundup 61 Bearish Pressure Building 60 Q4 Loss Widens 60 Calls Purchased 60 Files Annual Report 60 Guides FY# Quick Facts 60 Announces Organizational Changes 60 1Q Profit Falls 59 Guides Below 59 quotes/comstock/# * 59 Narrows Loss 59 4Q Profit Rises 59 Updates Guidance 59 Q4 Profit Declines 59 Guides FY# 59 Boosts Dividend 59 Q2 Profit Declines 58 Files Patent 58 Guides Q2 58 Q1 Profit Declines 57 Webcast Annual Meeting 57 2Q Profit Up 57 2Q Profit Falls 57 Beats Analyst 57 Achieves Milestone 57 Host Webcast 57 Inc. FY# Q3 57 3Q Profit Rises 57 Analyst Upgrades 57 Receives Patent 57 Hold Fourth Quarter 57 Announces Share Repurchase 57 Above Estimates 57 Analyst Actions 57 Guides Q4 57 1Q Profit Rises 57 Forecast Quick Facts 57 Patent Dispute 57 Extends Tender Offer 57 Raises PT 57 Raises Guidance 57 Provides Guidance 57 PROFILE CO 57 Provides Preliminary 57 3Q Profit Falls 56 Stock Buyback 56 Net Loss Widens 56 Movers roundup 56 Posts Strong 56 Finalizes Acquisition 56 Acquire Assets 56 Announces Enhancements 56 Introduces Next Generation 56 1Q Profit Up 56 Reiterates Buy 56 Q4 Profit Rises 56 Below Estimates 56 Q1 Profit Rises 56 Revenues Decline 56 Announces Definitive Agreement 56 Q3 Profit Declines 56 4Q Profit Up 56 Corp. FY# Q3 56 4Q Profit Falls 56 Stock Upgraded 56 Guides Q1 56 Foolish Forecast 56 Q3 Profit Rises 56 Upcoming Investor Conference 55 Develop Next Generation 55 Q2 Profit Rises 55 Unveils Latest 55 FDA Clears 55 Announces Additions 55 Maintains Buy 55 Begins Shipping 55 Reports Profitable 55 Patent Suit 55 Lowers Price 55 Quarterly Profit Rises 55 Upcoming Conferences 55 Schedules Fiscal 55 2Q Profit Rises 55 Share Repurchases 55 Complete Merger 55 Tops Estimates 55 Bullish Engulfing Pattern 55 Below Consensus